Oncternal Therapeutics (ONCT) Q3 2024 Earnings

Aug 8Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-3.11
-2.12
-1.13
-0.14

Details

Expected EPS
-3.033333
Actual EPS
-2.89
Surprise EPS
0.14
Surprise Percent
+4.73%

Description

⁨Oncternal Therapeutics⁩ (⁦ONCT⁩) has reported earnings of ⁦-2.89⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts